[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-001", "question": "A 45-year-old man with a history of migraine presents with acute onset of right-sided hemiparesis and aphasia. MRI shows restricted diffusion in the left middle cerebral artery territory, but no large vessel occlusion on angiography. Lumbar puncture reveals normal opening pressure, 5 WBCs/μL (all lymphocytes), protein 45 mg/dL, glucose 60 mg/dL, and negative oligoclonal bands. Serum testing is positive for anti-NMDA receptor antibodies. What is the most appropriate next step in management?", "options": ["Initiate intravenous thrombolysis", "Administer high-dose intravenous methylprednisolone", "Start rituximab infusion", "Perform plasmapheresis", "Administer acyclovir empirically"], "answer": "C", "answer_index": 2, "explanation": "The presentation suggests anti-NMDA receptor encephalitis mimicking stroke, and rituximab is indicated for refractory cases or as first-line in severe presentations per subspecialty guidelines. High-dose steroids are often initial, but in antibody-positive cases with stroke-like features, rituximab targets B-cell depletion more effectively. Plasmapheresis is an alternative but not superior in this context without evidence of fulminant progression.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: C (Contradiction) / N (No answer defensible). Verdict: No defensible answer. The vignette contains a fundamental contradiction: 'restricted diffusion in the left MCA territory' is the radiologic definition of an acute ischemic stroke, whereas the serology and intended answer imply anti-NMDA receptor encephalitis. These are distinct pathologies; autoimmune encephalitis typically presents with medial temporal T2/FLAIR hyperintensities, not vascular territory restricted diffusion (cytotoxic edema). Consequently, the stem describes two mutually exclusive conditions. Furthermore, even if the diagnosis of anti-NMDAR encephalitis is accepted (ignoring the MRI), the keyed answer (Rituximab) is incorrect as the 'next step.' Standard guidelines recommend first-line immunotherapy (corticosteroids, IVIG, or plasmapheresis) for initial management. Rituximab is a second-line agent reserved for refractory cases. Since Option B (Methylprednisolone) is a standard first-line treatment and is available, it is superior to the key. Minimal fix: Change MRI findings to 'T2 hyperintensities in the medial temporal lobes' and specify the patient 'failed initial steroid therapy' to justify Rituximab, or change the key to B.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: C (Contradiction) / N (No answer defensible). Verdict: No defensible answer. The vignette contains a fundamental contradiction: 'restricted diffusion in the left MCA territory' is the radiologic definition of an acute ischemic stroke, whereas the serology and intended answer imply anti-NMDA receptor encephalitis. These are distinct pathologies; autoimmune encephalitis typically presents with medial temporal T2/FLAIR hyperintensities, not vascular territory restricted diffusion (cytotoxic edema). Consequently, the stem describes two mutually exclusive conditions. Furthermore, even if the diagnosis of anti-NMDAR encephalitis is accepted (ignoring the MRI), the keyed answer (Rituximab) is incorrect as the 'next step.' Standard guidelines recommend first-line immunotherapy (corticosteroids, IVIG, or plasmapheresis) for initial management. Rituximab is a second-line agent reserved for refractory cases. Since Option B (Methylprednisolone) is a standard first-line treatment and is available, it is superior to the key. Minimal fix: Change MRI findings to 'T2 hyperintensities in the medial temporal lobes' and specify the patient 'failed initial steroid therapy' to justify Rituximab, or change the key to B.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-002", "question": "A 62-year-old woman with Parkinson's disease on levodopa/carbidopa develops sudden visual hallucinations and paranoia. She has no fever, normal vital signs, and her Unified Parkinson's Disease Rating Scale score has worsened by 15 points. CSF analysis shows 10 WBCs/μL (mononuclear), protein 55 mg/dL, and negative PCR for herpes simplex virus. What is the most likely underlying mechanism?", "options": ["Dopaminergic overstimulation in mesolimbic pathways", "Alpha-synuclein aggregation in occipital lobes", "Autoimmune encephalitis with anti-LGI1 antibodies", "Lewy body deposition in limbic structures", "Serotonergic imbalance from medication withdrawal"], "answer": "C", "answer_index": 2, "explanation": "This scenario points to anti-LGI1 encephalitis, which can mimic psychiatric decompensation in Parkinson's patients and is associated with faciobrachial dystonic seizures or hallucinations. Dopaminergic effects are common but do not explain the CSF pleocytosis. Lewy body involvement is typical in dementia with Lewy bodies but lacks the acute inflammatory CSF findings here.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item functions as a 'rule-out' question where a specific objective finding drives the answer despite base-rate probabilities. In a patient with Parkinson's disease, visual hallucinations are most commonly due to dopaminergic toxicity (Option A) or disease progression (Options B/D). However, the presence of CSF pleocytosis (10 WBCs/μL) and acute motor worsening (UPDRS +15) indicates an inflammatory or infectious process, effectively ruling out drug toxicity and pure neurodegeneration. Option C is the only choice that describes an inflammatory etiology (Autoimmune Encephalitis). While the vignette lacks specific features of anti-LGI1 encephalitis (e.g., faciobrachial dystonic seizures, hyponatremia), it is the unique best answer by elimination of the non-inflammatory distractors. The logic is sound for a board-style exam.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item functions as a 'rule-out' question where a specific objective finding drives the answer despite base-rate probabilities. In a patient with Parkinson's disease, visual hallucinations are most commonly due to dopaminergic toxicity (Option A) or disease progression (Options B/D). However, the presence of CSF pleocytosis (10 WBCs/μL) and acute motor worsening (UPDRS +15) indicates an inflammatory or infectious process, effectively ruling out drug toxicity and pure neurodegeneration. Option C is the only choice that describes an inflammatory etiology (Autoimmune Encephalitis). While the vignette lacks specific features of anti-LGI1 encephalitis (e.g., faciobrachial dystonic seizures, hyponatremia), it is the unique best answer by elimination of the non-inflammatory distractors. The logic is sound for a board-style exam.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-003", "question": "A 28-year-old woman at 32 weeks gestation presents with severe pelvic pain and vaginal bleeding. Ultrasound shows a low-lying placenta with abnormal lacunae and loss of the retroplacental clear space. MRI confirms myometrial thinning and turbulent flow voids. What is the most appropriate management strategy?", "options": ["Expectant management with bed rest", "Immediate cesarean delivery", "Uterine artery embolization", "Balloon tamponade post-delivery", "Prophylactic internal iliac artery ligation"], "answer": "E", "answer_index": 4, "explanation": "This describes placenta accreta spectrum, and prophylactic internal iliac artery ligation reduces hemorrhage risk during planned cesarean hysterectomy in high-risk cases. Immediate delivery risks uncontrolled bleeding without preparation. Embolization is adjunctive but not primary in antenatal planning for accreta.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with Placenta Accreta Spectrum (PAS) presenting at 32 weeks with 'severe pelvic pain and vaginal bleeding.' This presentation indicates an obstetric emergency (likely placental abruption or uterine rupture in the setting of PAS) requiring immediate stabilization and delivery (Emergency Cesarean Hysterectomy). The keyed answer (E) suggests 'Prophylactic internal iliac artery ligation' as the management strategy. This is logically and medically invalid for two reasons: 1) The patient is symptomatic and unstable, requiring delivery (Option B), not a prophylactic surgical adjunct used during a planned procedure. 2) Internal iliac artery ligation is a specific surgical technique, not a primary 'management strategy,' and is not the universal standard of care (Cesarean Hysterectomy is the standard). The rationale contradicts the stem by implying the case can be managed as a planned procedure, ignoring the 'severe pain and bleeding.' Option B is the only choice addressing the need for delivery, though it lacks the critical 'hysterectomy' detail. Thus, no option correctly describes the standard of care (Emergency Cesarean Hysterectomy), and the key is inappropriate for the acute presentation.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with Placenta Accreta Spectrum (PAS) presenting at 32 weeks with 'severe pelvic pain and vaginal bleeding.' This presentation indicates an obstetric emergency (likely placental abruption or uterine rupture in the setting of PAS) requiring immediate stabilization and delivery (Emergency Cesarean Hysterectomy). The keyed answer (E) suggests 'Prophylactic internal iliac artery ligation' as the management strategy. This is logically and medically invalid for two reasons: 1) The patient is symptomatic and unstable, requiring delivery (Option B), not a prophylactic surgical adjunct used during a planned procedure. 2) Internal iliac artery ligation is a specific surgical technique, not a primary 'management strategy,' and is not the universal standard of care (Cesarean Hysterectomy is the standard). The rationale contradicts the stem by implying the case can be managed as a planned procedure, ignoring the 'severe pain and bleeding.' Option B is the only choice addressing the need for delivery, though it lacks the critical 'hysterectomy' detail. Thus, no option correctly describes the standard of care (Emergency Cesarean Hysterectomy), and the key is inappropriate for the acute presentation.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-004", "question": "A 35-year-old woman with endometriosis undergoes laparoscopic excision and develops postoperative fever, leukocytosis, and pelvic pain. CT shows a 5 cm complex adnexal mass with gas bubbles. Blood cultures are negative, but vaginal cultures grow mixed anaerobes. What is the most likely diagnosis?", "options": ["Ovarian abscess from bowel perforation", "Endometrioma superinfection", "Tubo-ovarian abscess from pelvic inflammatory disease", "Postoperative hematoma with secondary infection", "Clostridial myonecrosis of the uterus"], "answer": "A", "answer_index": 0, "explanation": "Bowel perforation during endometriosis surgery can lead to ovarian abscess with gas-forming anaerobes, explaining the imaging and cultures. Endometrioma infection is less likely without prior instrumentation. Tubo-ovarian abscess typically involves gonadal pathogens, not mixed anaerobes from bowel flora.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with postoperative fever, pelvic pain, and a gas-containing adnexal mass following laparoscopic endometriosis excision. The presence of gas bubbles within a complex mass, combined with the growth of mixed anaerobes, is highly suggestive of a connection to the bowel, making bowel perforation (Option A) the most likely and critical diagnosis. Endometriosis surgery carries a known risk of bowel injury. While an infected hematoma (Option D) or endometrioma (Option B) could theoretically involve gas-forming organisms, the specific finding of gas bubbles in the context of recent pelvic surgery is a classic 'red flag' for bowel perforation. The provided rationale contains a logical error—it states endometrioma infection is unlikely 'without prior instrumentation,' ignoring the fact that the stem explicitly states the patient just underwent surgery. However, this flaw is in the explanation text, not the item itself. The item allows for a unique best answer based on standard surgical complications.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with postoperative fever, pelvic pain, and a gas-containing adnexal mass following laparoscopic endometriosis excision. The presence of gas bubbles within a complex mass, combined with the growth of mixed anaerobes, is highly suggestive of a connection to the bowel, making bowel perforation (Option A) the most likely and critical diagnosis. Endometriosis surgery carries a known risk of bowel injury. While an infected hematoma (Option D) or endometrioma (Option B) could theoretically involve gas-forming organisms, the specific finding of gas bubbles in the context of recent pelvic surgery is a classic 'red flag' for bowel perforation. The provided rationale contains a logical error—it states endometrioma infection is unlikely 'without prior instrumentation,' ignoring the fact that the stem explicitly states the patient just underwent surgery. However, this flaw is in the explanation text, not the item itself. The item allows for a unique best answer based on standard surgical complications.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-005", "question": "A 58-year-old man with hypertrophic cardiomyopathy presents with syncope. Echocardiogram shows left ventricular outflow tract gradient of 80 mmHg at rest, increasing to 120 mmHg with Valsalva. He is on beta-blockers but remains symptomatic. Genetic testing reveals a MYH7 mutation. What is the most appropriate next intervention?", "options": ["Alcohol septal ablation", "Surgical myectomy", "Implantable cardioverter-defibrillator placement", "Dual-chamber pacing", "Mavacamten therapy"], "answer": "E", "answer_index": 4, "explanation": "Mavacamten, a cardiac myosin inhibitor, is indicated for symptomatic obstructive hypertrophic cardiomyopathy refractory to beta-blockers, targeting the underlying MYH7-related hypercontractility. Alcohol ablation and myectomy are invasive options for severe cases, but mavacamten offers medical management first. ICD is for arrhythmia risk, not outflow obstruction.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with severe obstructive hypertrophic cardiomyopathy (HCM) (LVOT gradient >50 mmHg) who remains symptomatic despite first-line medical therapy (beta-blockers). The key decision point is selecting the next step in management. Mavacamten (Option E), a cardiac myosin inhibitor, is FDA-approved and indicated for symptomatic obstructive HCM (NYHA class II-III) as an escalation of medical therapy. Standard of care dictates exhausting medical options (including disopyramide or mavacamten) before proceeding to invasive Septal Reduction Therapy (SRT) such as myectomy (Option B) or alcohol septal ablation (Option A). While syncope is a risk factor for sudden cardiac death that might prompt ICD evaluation (Option C), the presence of a massive 120 mmHg gradient strongly suggests a hemodynamic/obstructive cause for the syncope, making obstruction relief the primary 'next intervention.' The item accurately reflects modern management algorithms incorporating novel therapeutics.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with severe obstructive hypertrophic cardiomyopathy (HCM) (LVOT gradient >50 mmHg) who remains symptomatic despite first-line medical therapy (beta-blockers). The key decision point is selecting the next step in management. Mavacamten (Option E), a cardiac myosin inhibitor, is FDA-approved and indicated for symptomatic obstructive HCM (NYHA class II-III) as an escalation of medical therapy. Standard of care dictates exhausting medical options (including disopyramide or mavacamten) before proceeding to invasive Septal Reduction Therapy (SRT) such as myectomy (Option B) or alcohol septal ablation (Option A). While syncope is a risk factor for sudden cardiac death that might prompt ICD evaluation (Option C), the presence of a massive 120 mmHg gradient strongly suggests a hemodynamic/obstructive cause for the syncope, making obstruction relief the primary 'next intervention.' The item accurately reflects modern management algorithms incorporating novel therapeutics.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-006", "question": "A 70-year-old woman with atrial fibrillation on apixaban develops acute chest pain. Coronary angiography shows spontaneous coronary artery dissection in the left anterior descending artery. She is hemodynamically stable with TIMI 3 flow. What is the most appropriate management?", "options": ["Percutaneous coronary intervention with stenting", "Continuation of apixaban with close monitoring", "Switch to dual antiplatelet therapy", "Surgical bypass grafting", "Conservative management with beta-blockers"], "answer": "E", "answer_index": 4, "explanation": "Conservative management with beta-blockers is preferred for stable spontaneous coronary artery dissection with preserved flow, as it promotes healing and reduces shear stress. Anticoagulation like apixaban increases bleeding risk in dissection. PCI is reserved for unstable cases due to high complication rates.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a patient with stable Spontaneous Coronary Artery Dissection (SCAD) with preserved coronary flow (TIMI 3). Current consensus guidelines (AHA/ACC/ESC) recommend conservative management as the first-line strategy for such patients, making Option E the correct best answer. Beta-blockers are the cornerstone of medical therapy to reduce arterial shear stress and prevent dissection propagation. PCI (Option A) is contraindicated in stable cases due to the high risk of iatrogenic dissection extension and technical failure. Regarding the patient's atrial fibrillation, therapeutic anticoagulation (Option B) is typically discontinued in the acute phase of SCAD because it promotes intramural hematoma expansion, which can worsen the obstruction; the acute risk of dissection progression generally outweighs the short-term stroke risk. Option C (DAPT) is often used, but beta-blockade is the primary mechanism-based therapy, and 'Conservative management' (Option E) correctly identifies the overall strategy versus invasive options. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a patient with stable Spontaneous Coronary Artery Dissection (SCAD) with preserved coronary flow (TIMI 3). Current consensus guidelines (AHA/ACC/ESC) recommend conservative management as the first-line strategy for such patients, making Option E the correct best answer. Beta-blockers are the cornerstone of medical therapy to reduce arterial shear stress and prevent dissection propagation. PCI (Option A) is contraindicated in stable cases due to the high risk of iatrogenic dissection extension and technical failure. Regarding the patient's atrial fibrillation, therapeutic anticoagulation (Option B) is typically discontinued in the acute phase of SCAD because it promotes intramural hematoma expansion, which can worsen the obstruction; the acute risk of dissection progression generally outweighs the short-term stroke risk. Option C (DAPT) is often used, but beta-blockade is the primary mechanism-based therapy, and 'Conservative management' (Option E) correctly identifies the overall strategy versus invasive options. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-007", "question": "A 40-year-old man returning from West Africa presents with fever, myalgias, and petechial rash. Labs show thrombocytopenia, elevated liver enzymes, and PCR positive for Lassa virus. He develops acute kidney injury with oliguria. What is the most appropriate therapeutic intervention?", "options": ["Intravenous ribavirin", "Supportive care with hemodialysis", "Convalescent plasma transfusion", "Favipiravir administration", "Monoclonal antibody therapy"], "answer": "A", "answer_index": 0, "explanation": "Intravenous ribavirin is the mainstay for Lassa fever, reducing mortality especially when initiated early, and it addresses viremia in cases with renal involvement. Supportive care is essential but not sufficient alone. Favipiravir is investigational and not standard for Lassa.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic case of Lassa fever (travel history, fever, hemorrhage, thrombocytopenia, hepatitis, confirmed PCR) complicated by acute kidney injury (AKI). The question asks for the most appropriate therapeutic intervention. Intravenous ribavirin (Option A) is the historically established, guideline-endorsed specific antiviral therapy for Lassa fever, particularly effective when initiated early. While the efficacy of ribavirin is increasingly debated in modern literature, it remains the standard board-exam answer. Option B (Supportive care with hemodialysis) is clinically essential for managing the complication of oliguric AKI, but in the context of a 'most appropriate intervention' question for a specific infectious disease, the etiology-specific treatment (antiviral) is prioritized over supportive measures unless the patient is explicitly described as unstable/requiring immediate resuscitation (e.g., hyperkalemic arrest), which is not detailed here. Options C, D, and E represent investigational or non-standard therapies. Therefore, A is the unique best answer under standard medical board testing logic.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic case of Lassa fever (travel history, fever, hemorrhage, thrombocytopenia, hepatitis, confirmed PCR) complicated by acute kidney injury (AKI). The question asks for the most appropriate therapeutic intervention. Intravenous ribavirin (Option A) is the historically established, guideline-endorsed specific antiviral therapy for Lassa fever, particularly effective when initiated early. While the efficacy of ribavirin is increasingly debated in modern literature, it remains the standard board-exam answer. Option B (Supportive care with hemodialysis) is clinically essential for managing the complication of oliguric AKI, but in the context of a 'most appropriate intervention' question for a specific infectious disease, the etiology-specific treatment (antiviral) is prioritized over supportive measures unless the patient is explicitly described as unstable/requiring immediate resuscitation (e.g., hyperkalemic arrest), which is not detailed here. Options C, D, and E represent investigational or non-standard therapies. Therefore, A is the unique best answer under standard medical board testing logic.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-008", "question": "A 55-year-old immunocompromised patient with lung transplant develops dyspnea and ground-glass opacities on CT. Bronchoalveolar lavage PCR is positive for Pneumocystis jirovecii, but serum beta-D-glucan is negative. He is on trimethoprim-sulfamethoxazole prophylaxis. What explains the breakthrough infection?", "options": ["Dihydropteroate synthase gene mutation", "Non-adherence to prophylaxis", "Concurrent cytomegalovirus co-infection", "Inadequate dosing in obesity", "Atovaquone cross-resistance"], "answer": "A", "answer_index": 0, "explanation": "Mutations in the dihydropteroate synthase gene confer resistance to sulfamethoxazole in Pneumocystis, leading to breakthrough despite prophylaxis in immunocompromised hosts. Non-adherence is common but less likely with negative beta-D-glucan suggesting low burden. CMV co-infection exacerbates but does not cause resistance.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question addresses the mechanism of breakthrough Pneumocystis jirovecii pneumonia (PCP) in a patient on trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis. The keyed answer (A) correctly identifies mutations in the dihydropteroate synthase (DHPS) gene as the established mechanism of sulfonamide resistance in Pneumocystis, which is strongly associated with breakthrough infection in patients with prior sulfa exposure. While non-adherence (B) is a common real-world reason for prophylaxis failure, standard board-exam framing assumes adherence when a patient is stated to be 'on' a medication, unless behavioral clues suggest otherwise. The vignette includes a negative beta-D-glucan (BDG) result; while the author uses this to argue for 'low burden' (favoring resistance over the high burden of non-adherence), clinically, a negative BDG with positive PCR often raises the question of colonization vs. infection. However, given the explicit symptoms (dyspnea) and imaging (ground-glass opacities), the stem establishes active infection as the premise. Therefore, the specific pathophysiologic mechanism (A) is the intended and most defensible best answer compared to the behavioral speculation in (B).\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question addresses the mechanism of breakthrough Pneumocystis jirovecii pneumonia (PCP) in a patient on trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis. The keyed answer (A) correctly identifies mutations in the dihydropteroate synthase (DHPS) gene as the established mechanism of sulfonamide resistance in Pneumocystis, which is strongly associated with breakthrough infection in patients with prior sulfa exposure. While non-adherence (B) is a common real-world reason for prophylaxis failure, standard board-exam framing assumes adherence when a patient is stated to be 'on' a medication, unless behavioral clues suggest otherwise. The vignette includes a negative beta-D-glucan (BDG) result; while the author uses this to argue for 'low burden' (favoring resistance over the high burden of non-adherence), clinically, a negative BDG with positive PCR often raises the question of colonization vs. infection. However, given the explicit symptoms (dyspnea) and imaging (ground-glass opacities), the stem establishes active infection as the premise. Therefore, the specific pathophysiologic mechanism (A) is the intended and most defensible best answer compared to the behavioral speculation in (B).", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-009", "question": "A 50-year-old woman with rheumatoid arthritis on tofacitinib presents with symmetric polyarthritis flare, fever, and macular rash. Labs show pancytopenia, ferritin 10,000 ng/mL, triglycerides 400 mg/dL, and fibrinogen 100 mg/dL. Bone marrow biopsy reveals hemophagocytosis. What is the most appropriate initial treatment?", "options": ["High-dose glucocorticoids", "Cyclosporine A", "Anakinra", "Etoposide-based chemotherapy", "Intravenous immunoglobulin"], "answer": "C", "answer_index": 2, "explanation": "Anakinra, an IL-1 inhibitor, is effective for macrophage activation syndrome in rheumatoid arthritis, targeting cytokine storm and improving survival without broad immunosuppression. Glucocorticoids are adjunctive but insufficient alone in JAK inhibitor-associated cases. Etoposide is for refractory HLH but not first-line here.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The patient presents with classic signs of Macrophage Activation Syndrome (MAS) secondary to Rheumatoid Arthritis (RA), indicated by fever, rash, pancytopenia, hyperferritinemia, and hemophagocytosis. The question asks for the \\\"most appropriate initial treatment.\\\" High-dose glucocorticoids (Option A) are the universally accepted, standard-of-care first-line intervention for stabilizing MAS. While Anakinra (Option C) is a highly effective, targeted therapy often used early or in refractory cases, it is rarely the sole initial treatment replacing steroids in standard guidelines; it is typically added to steroids. The provided explanation dismisses glucocorticoids as \\\"insufficient alone,\\\" which contradicts mainstream rheumatology protocols (e.g., ACR/EULAR) that prioritize pulse steroids as the immediate first step. Consequently, Option A is the most defensible answer for \\\"initial treatment,\\\" while Option C is a valid but typically secondary or concurrent step. This creates a situation where the keyed answer is not the unique best answer compared to the standard of care, resulting in multiple defensible options or a miskeyed item.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The patient presents with classic signs of Macrophage Activation Syndrome (MAS) secondary to Rheumatoid Arthritis (RA), indicated by fever, rash, pancytopenia, hyperferritinemia, and hemophagocytosis. The question asks for the \"most appropriate initial treatment.\" High-dose glucocorticoids (Option A) are the universally accepted, standard-of-care first-line intervention for stabilizing MAS. While Anakinra (Option C) is a highly effective, targeted therapy often used early or in refractory cases, it is rarely the sole initial treatment replacing steroids in standard guidelines; it is typically added to steroids. The provided explanation dismisses glucocorticoids as \"insufficient alone,\" which contradicts mainstream rheumatology protocols (e.g., ACR/EULAR) that prioritize pulse steroids as the immediate first step. Consequently, Option A is the most defensible answer for \"initial treatment,\" while Option C is a valid but typically secondary or concurrent step. This creates a situation where the keyed answer is not the unique best answer compared to the standard of care, resulting in multiple defensible options or a miskeyed item.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "question_id": "20251201T041413890Z_grok-4-0709_seed124-010", "question": "A 65-year-old man with giant cell arteritis on prednisone taper develops jaw claudication and vision loss. ESR is 80 mm/hr, and temporal artery biopsy is negative. CTA shows aortic arch involvement. What is the most appropriate escalation in therapy?", "options": ["Increase prednisone to 60 mg daily", "Add methotrexate", "Initiate tocilizumab", "Start cyclophosphamide", "Perform temporal artery ultrasound"], "answer": "C", "answer_index": 2, "explanation": "Tocilizumab, an IL-6 inhibitor, is indicated for refractory giant cell arteritis with large vessel involvement, reducing relapse and steroid requirements. High-dose prednisone is initial but inadequate for escalation in biopsy-negative cases. Methotrexate is steroid-sparing but less effective for vision-threatening disease.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with Large Vessel Giant Cell Arteritis (LV-GCA) experiencing a relapse characterized by acute vision loss. This is a medical emergency. The standard of care for GCA-associated vision loss is immediate high-dose systemic corticosteroids (typically IV pulse methylprednisolone followed by high-dose oral) to prevent permanent blindness. Option A (Increase prednisone to 60 mg) represents the necessary immediate re-induction of high-dose steroids (though IV is preferred). Option C (Initiate tocilizumab) is the correct evidence-based adjunctive therapy for relapsing/refractory GCA (GiACTA trial) but is not an acute rescue therapy for ischemic vision loss due to its slower onset of action. The item is logically invalid because it forces a choice between the immediate sight-saving intervention (A) and the long-term steroid-sparing escalation (C). In clinical practice, a physician would do both (or IV steroids + C). Prioritizing C over A in the setting of acute vision loss is medically unsafe, as Tocilizumab monotherapy or prioritization would not adequately treat the acute ischemia. The stem is underspecified regarding whether acute steroid rescue has already occurred; without that assumption, A is the priority for patient safety.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with Large Vessel Giant Cell Arteritis (LV-GCA) experiencing a relapse characterized by acute vision loss. This is a medical emergency. The standard of care for GCA-associated vision loss is immediate high-dose systemic corticosteroids (typically IV pulse methylprednisolone followed by high-dose oral) to prevent permanent blindness. Option A (Increase prednisone to 60 mg) represents the necessary immediate re-induction of high-dose steroids (though IV is preferred). Option C (Initiate tocilizumab) is the correct evidence-based adjunctive therapy for relapsing/refractory GCA (GiACTA trial) but is not an acute rescue therapy for ischemic vision loss due to its slower onset of action. The item is logically invalid because it forces a choice between the immediate sight-saving intervention (A) and the long-term steroid-sparing escalation (C). In clinical practice, a physician would do both (or IV steroids + C). Prioritizing C over A in the setting of acute vision loss is medically unsafe, as Tocilizumab monotherapy or prioritization would not adequately treat the acute ischemia. The stem is underspecified regarding whether acute steroid rescue has already occurred; without that assumption, A is the priority for patient safety.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}]